Dimitri Azar
Dimitri Azar is an American ophthalmologist, professor, inventor and current CEO of Lacristat, a San Jose based ophthalmology bio-tech company.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Dimitri Azar is an American ophthalmologist, professor, inventor and current CEO of Lacristat, a San Jose based ophthalmology bio-tech company. Dr. Azar previously founded Twenty Twenty Therapeutics, a joint venture established by Santen and Verily. The Twenty Twenty products were ultimately transferred to Santen and Verily in September 2024.
Azar served as a board member of Novartis and a member of the scientific advisory board of Verily, Alphabet's Life sciences research organization. He served as dean of the College of Medicine at the University of Illinois at Chicago (UIC) from 2011 to 2018, and is currently Distinguished Professor and Executive Dean Emeritus.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1372189872 under CC BY-SA 4.0; modifications have been made.